Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF JULY 26,1995 PSA#1396

U.S. Agency International Development, Office of Procurement, Room 1569, SA-14, Washington, D.C. 20523-1427

Q -- MEDICAL SERVICES DUE 080195 POC John B. Tomaro, Ph.D., M.P.H., Office of Health and Nutrition, USAID G/PHN/HN, Suite 1200 - SA-18, Washington, DC. 20523-1817, or FAX: 703-875-4523 The U.S. Agency for International Development (USAID) proposes to enter into a non-competitive, multi-year cooperative agreement with the Program for Appropriate Technology in Health (PATH) of Seattle, Washington to develop, produce, introduce and market low- cost health and nutrition technologies that address high priority health conditions (e.g., malaria, acute respiratory infection, diarrhea, sexually transmitted diseases) in developing countries. Technologies to be developed include diagnostic kits, safe injection devices, and other, simple low-cost technologies needed to enhance the effectiveness of primary health care systems in developing countries. This is a follow-on program to cooperative agreement #DPE-5968-A-00-0025-00. Before making the proposed award, the Office of Health and Nutrition of USAID's Center for Population, Health and Nutrition seeks to identify interested qualified organizations with a full range of in-house expertise and a well-documented record of experience in the development and introduction of low-cost, appropriate health technologies in a developing world setting. Key elements of relevant institutional capacity are experience in: a) undertaking laboratory research necessary to develop or adapt potentially appropriate technologies; b) conducting field trials of technologies in a variety of developing world settings; c) carrying out assessments of developing country markets and the local capacity to produce and/or package specific technologies and market locally produced items; d) negotiating product licensing and marketing agreement with private companies in the U.S. and overseas; e) collaborating with key international agencies (e.g., WHO and UNICEF) and the official of ministries of health to refine product specifications, test prototypes, and facilitate the introduction, distribution and availability of new, low-cost technologies. Institutions with the requisite qualifications may submit expressions of interest, and are asked to submit a brief (maximum 3 pages) description of their in-house capabilities and relevant international experience by August 1, 1995 (0205)

Loren Data Corp. http://www.ld.com (SYN# 0095 19950725\Q-0022.SOL)


Q - Medical Services Index Page